Roivant Sciences Ltd. (ROIV) Earnings History
Annual and quarterly earnings data from 2019 to 2024
Loading earnings history...
ROIV EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ROIV Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 96.9% | -3453.3% | -592.0% |
| 2023 | 95.1% | 13746.9% | 13294.2% |
| 2022 | 78.6% | -1917.9% | -1646.6% |
| 2021 | 83.8% | -2444.8% | -1528.9% |
| 2020 | 91.4% | -4500.5% | -3400.9% |
Download Data
Export ROIV earnings history in CSV or JSON format
Free sign-in required to download data
Roivant Sciences Ltd. (ROIV) Earnings Overview
As of May 8, 2026, Roivant Sciences Ltd. (ROIV) reported trailing twelve-month net income of -$809M, reflecting -104.6% year-over-year growth. The company earned $-0.00 per diluted share over the past four quarters, with a net profit margin of -592.0%.
Looking at the long-term picture, ROIV's historical earnings data spans multiple years. The company achieved its highest annual net income of $4.35B in fiscal 2023.
Roivant Sciences Ltd. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including BHVN (-$648M net income), IMVT (-$464M net income), KYMR (-$315M net income, -794.4% margin), ROIV has comparable earnings metrics. Compare ROIV vs BHVN →
ROIV Earnings vs Peers
Earnings metrics vs comparable public companies
ROIV Historical Earnings Data (2019–2024)
6 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$172M | -104.0% | -$1.00B | $-0.24 | -592.0% | -3453.3% |
| 2023 | $4.35B | +531.0% | $4.50B | $5.23 | 13294.2% | 13746.9% |
| 2022 | -$1.01B | -19.4% | -$1.18B | $-1.42 | -1646.6% | -1917.9% |
| 2021 | -$845M | -4.5% | -$1.35B | $-1.26 | -1528.9% | -2444.8% |
| 2020 | -$809M | -167.4% | -$1.07B | $-1.18 | -3400.9% | -4500.5% |
| 2019 | $1.20B | - | -$532M | $1.75 | 1773.6% | -786.6% |
Full ROIV Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See ROIV's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ROIV Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ROIV vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonROIV — Frequently Asked Questions
Quick answers to the most common questions about buying ROIV stock.
Is ROIV growing earnings?
ROIV EPS fell to $-0.00, with earnings declining -104.6%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-809M.
What are ROIV's profit margins?
Roivant Sciences Ltd. net margin is -592.0%, with operating margin at -3453.3%. Below-average margins reflect competitive or cost pressures.
How consistent are ROIV's earnings?
ROIV earnings data spans 2019-2024. The declining earnings trend is -104.6% YoY. Historical data enables comparison across business cycles.